Astec Lifesciences share price

High risk
  • 57%Low risk
  • 57%Moderate risk
  • 57%Balanced risk
  • 57%High risk
  • 57%Extreme risk
  • ₹756.70(2.17%)
    June 20, 2025 15:24:06 PM IST
    • NSE
    • BSE
  • Vol : 105.37K (NSE + BSE)
    Last 20 day avg : 41.96 K

Astec Lifesciences is trading 2.17% upper at Rs 756.70 as compared to its last closing price. Astec Lifesciences has been trading in the price range of 786.10 & 737.00. Astec Lifesciences has given -24.23% in this year & -4.03% in the last 5 days. The company posted a net profit of -16.09 Crores in its last quarter.Listed peers of Astec Lifesciences include Excel Industries (1.90%), J.g.chemicals (2.95%), Astec Lifesciences (2.17%).The Mutual Fund holding in Astec Lifesciences was at 3.96% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Astec Lifesciences was at 0.25% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 22, 2025, 06:05 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    6.33
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    0.00
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.94
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    2.36
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
737.00
Highest
786.10
52 week range
Lowest
635.95
Highest
1,487.65
Astec Lifesciences News
Astec Lifesciences Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is not profitable
    • financial-insightsThe company's revenue fell during March quarter by 22.26% from Rs 153.75 crore to Rs 119.53 crore, year-on-year
    • financial-insightsThe company has increased its March quarter loss by 1552.04% from Rs 0.97 crore to Rs 16.09 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Astec Lifesciences Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 794.78
  • R2
  • 917.17
  • R3
  • 986.38
Pivot725.57
  • S1
  • 603.18
  • S2
  • 533.97
  • S3
  • 411.58
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Astec Lifesciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Excel Industries
Moderately Bullish
1,235.401.901,569.0318.070.971.120.14
J.g.chemicals
Bullish
394.002.951,543.9323.913.29-0.01
Astec Lifesciences
Bearish
756.702.171,491.37-6.33-119.28
Ultramarine And Pigments
Neutral
502.000.651,462.1819.581.511.197.54
Punjab Chemicals And Crop Prot
Bullish
1,195.001.501,455.8734.974.020.2519.13
Astec Lifesciences Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Astec Lifesciences is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 70.87%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has decreased by 0.95 percentage points from previous quarter
    • InsightsMutual Funds holding has decreased by 0.04 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    Tata Retirement Savings Progressive Fund Growth
    NA
    • Amount Invested (Cr.) 11.69
    • % of AUM 0.56
    Tata Retirement Savings Conservative Fund Growth
    NA
    • Amount Invested (Cr.) 0.52
    • % of AUM 0.29
    ICICI Prudential Commodities Fund Regular Growth
    NA
    • Amount Invested (Cr.) 7.56
    • % of AUM 0.28
    ICICI Prudential Retirement Fund Hybrid Aggressive Plan Regular Growth
    NA
    • Amount Invested (Cr.) 0.71
    • % of AUM 0.08
    Nippon India Small Cap Fund - Growth
    4/5
    • Amount Invested (Cr.) 30.99
    • % of AUM 0.05
    Astec Lifesciences Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-04-23Audited Results
    2025-01-27Quarterly Results
    2024-10-25Quarterly Results
    2024-07-29Quarterly Results
    2024-05-02Audited Results
    About the company Astec Lifesciences
    • IndustryChemical Manufacturing
    • ISININE563J01010
    • BSE Code533138
    • NSE CodeASTEC
    Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
    • Management Info
    • Mugdha KhareChief Financial Officer
    • Tejashree PradhanCompliance Officer, Company Secretary
    • Burjis GodrejManaging Director, Non-Independent Director
    Astec Lifesciences Share Price FAQs

    Astec Lifesciences is trading at 756.70 as on Fri Jun 20 2025 09:54:06. This is 2.17% upper as compared to its previous closing price of 740.65.

    The market capitalization of Astec Lifesciences is 1491.37 Cr as on Fri Jun 20 2025 09:54:06.

    The 52 wk high for Astec Lifesciences is 1487.65 whereas the 52 wk low is 635.95

    Astec Lifesciences can be analyzed on the following key metrics -

    • TTM P/E:
    • Sector P/E: 17.73
    • Dividend Yield: 0.00%
    • D/E ratio: 2.36

    Astec Lifesciences reported a net profit of -134.75 Cr in 2025.

    The Mutual Fund Shareholding was 3.96% at the end of 31 Mar 2025.

    Quick Links
    EQUITY QUICK LINKS
    Astec Lifesciences QUICK LINKS
    FROM MARKETS
    RELATED LINKS
    Quarterly Results
    Business News/Market/Market Stats/   Astec Lifesciences share price

    Wait for it…

    Log in to our website to save your bookmarks. It'll just take a moment.